TEXAS CAPITAL BANCSHARES INC/TX

TCBIO ·Financial, Banks - Regional, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item FY2026 FY2025 FY2024 FY2023 FY2022 FY2021 FY2020 FY2019
Revenue $1.26B $932.3M $1.08B $1.23B $907.1M $1.05B $1.07B
Cost of Revenue
Gross Profit
Gross Margin
Operating Expenses
Research & Development
SG&A Expense
Operating Income $432.7M $107.1M $962.4M $700.2M $445.8M $280.0M $781.9M
Operating Margin 34.5% 11.5% 89.5% 57.1% 49.1% 26.6% 73.0%
Interest Expense $715.8M $268.5M $107.7M $188.1M $385.6M
Pretax Income $432.7M $107.1M $246.6M $431.8M $338.1M $91.9M $396.3M
Income Tax Expense $102.5M $29.6M $57.5M $99.3M $84.1M $25.7M $84.3M
Net Income $330.2M $77.5M $189.1M $332.5M $253.9M $66.3M $312.0M
Net Margin 26.3% 8.3% 17.6% 27.1% 28.0% 6.3% 29.1%
EPS (Basic) $6.86 $1.29 $3.58 $6.25 $4.65 $1.12 $6.01
EPS (Diluted) $6.79 $1.28 $3.54 $6.18 $4.60 $1.12 $5.99
Shares Outstanding (Basic) 44.2M 45.6M 46.6M 48.1M 50.5M 50.6M 50.4M 50.3M
Shares Outstanding (Diluted) 44.2M 46.1M 47.0M 48.6M 51.0M 51.1M 50.6M 50.4M
Dividends Per Share
← Newer Page 1 of 3 Older →